Publications by authors named "Yuichi Shiraishi"

The KEAP1-NRF2 system plays a crucial role in responding to oxidative and electrophilic stress. Its dysregulation can cause the overexpression of downstream genes, a known cancer hallmark. Understanding and detecting abnormal KEAP1-NRF2 activity is essential for understanding disease mechanisms and identifying therapeutic targets.

View Article and Find Full Text PDF

Extranodal NK/T-cell lymphoma (ENKTCL) is an Epstein-Barr virus (EBV)-related neoplasm preferentially involving the upper aerodigestive tract. Here we show that NK-cell-specific Trp53 disruption in mice leads to the development of NK-cell lymphomas after long latency, which involve not only the hematopoietic system but also the salivary glands. Before tumor onset, Trp53 knockout causes extensive gene expression changes, resulting in immature NK-cell expansion, exclusively in the salivary glands.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how genetic factors regulate protein expression using protein quantitative trait loci (pQTLs) and highlights differences from traditional mRNA expression studies (eQTLs).
  • Analyzing data from over 4,000 samples, researchers found that fine-mapped pQTLs are linked to missense variants and show distinct mechanisms from eQTLs, indicating different regulatory influences.
  • The research reveals a negative correlation between ABO gene mRNA and protein levels due to genetic linkage, showcasing the complexities in the relationship between these expression types.
View Article and Find Full Text PDF

Purpose: HER2-targeted therapies in ERBB2-amplified metastatic colorectal cancer (mCRC) are effective; however, a notable portion of patients do not respond to treatment, and secondary resistance occurs in most patients receiving these treatments. The purpose of this study was to investigate determinants of treatment efficacy and resistance in patients with ERBB2-amplified mCRC who received HER2-targeted therapy by analyzing multiomics data.

Experimental Design: We investigated genomic data from a nationwide large cancer genomic screening project, the SCRUM-Japan project.

View Article and Find Full Text PDF
Article Synopsis
  • Ovarian clear cell carcinoma (OCCC) is a tough-to-treat gynecological cancer that shows resistance to chemotherapy, with its underlying mechanisms not fully understood.
  • Recent research combined single-cell analyses and spatial transcriptomics on surgical specimens to identify a resistant subpopulation of OCCC associated with high HIF activity found near cancer-associated fibroblasts (CAFs).
  • The study revealed that the growth factor PDGF contributes to this chemoresistance, and using the drug ripretinib can target CAFs, enhancing the effectiveness of conventional chemotherapy like carboplatin against OCCC.
View Article and Find Full Text PDF

Extranodal NK/T-cell lymphoma (ENKTCL) is an Epstein-Barr virus (EBV)-related neoplasm with male dominance and a poor prognosis. A better understanding of the genetic alterations and their functional roles in ENKTCL could help improve patient stratification and treatments. In this study, we performed a comprehensive genetic analysis of 178 ENKTCL cases to delineate the landscape of mutations, copy number alterations (CNA), and structural variations, identifying 34 driver genes including six previously unappreciated ones, namely, HLA-B, HLA-C, ROBO1, CD58, POT1, and MAP2K1.

View Article and Find Full Text PDF

Transient abnormal myelopoiesis (TAM) is a common complication in newborns with Down syndrome (DS). It commonly progresses to myeloid leukemia (ML-DS) after spontaneous regression. In contrast to the favorable prognosis of primary ML-DS, patients with refractory/relapsed ML-DS have poor outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • Innovations in sequencing technology have improved the detection of genetic mutations related to inherited diseases, yet many patients remain undiagnosed due to limitations in current methods.
  • The study introduces a new computational workflow for target adaptive sampling long-read sequencing (TAS-LRS) that enhances diagnostic accuracy by effectively identifying both single nucleotide variants and complex structural variations.
  • The TAS-LRS method not only discovered new mutations related to familial adenomatous polyposis and Lynch syndrome but also demonstrated the potential to analyze off-target reads for comprehensive genetic risk assessments.
View Article and Find Full Text PDF

To identify genes important for colorectal cancer (CRC) development and metastasis, we established a new metastatic mouse organoid model using Sleeping Beauty (SB) transposon mutagenesis. Intestinal organoids derived from mice carrying actively mobilizing SB transposons, an activating KrasG12D, and an inactivating ApcΔ716 allele, were transplanted to immunodeficient mice. While 66.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the early stages of tumor development, specifically focusing on lung adenocarcinomas like adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma.
  • Researchers conducted comprehensive genomic analysis on 76 lung cancer samples, combining sequencing data with transcriptomic and epigenomic information.
  • Findings indicate that very early-stage tumors have minimal somatic mutations, primarily in key driver mutations, leading to copy number changes and global DNA hypomethylation as the disease progresses, particularly in Noguchi type B tumors.
View Article and Find Full Text PDF
Article Synopsis
  • There is currently limited understanding of how alterations in fibroblast growth factor receptor 3 (FGFR3) affect bladder cancer (BLCA) and its tumor microenvironment (TME).
  • A study involving multi-omics analysis of BLCA tissues showed that aFGFR3 alterations are found in 44% of non-muscle invasive cases and 15% of muscle-invasive cases, affecting their immune response and tumor characteristics.
  • Notably, the LumP subtype in aFGFR3 cases responded significantly better to checkpoint inhibitors compared to their intact FGFR3 counterparts, suggesting that FGFR3 status influences treatment outcomes in bladder cancer.
View Article and Find Full Text PDF
Article Synopsis
  • Chronic inflammation is linked to the growth and worsening of colorectal cancer (CRC), prompting research on the underlying molecular mechanisms.
  • In vivo screening revealed 142 frequently mutated genes in inflammation-associated colon tumors, highlighting the role of senescence and TGFβ-activin signaling pathways.
  • The study identifies potential therapeutic targets, such as the Cdk4/6 inhibitor and tumor suppressor genes Arhgap5 and Mecom, emphasizing the significance of senescence pathway inactivation in CRC within inflammatory environments.
View Article and Find Full Text PDF
Article Synopsis
  • * In a study of 50 platinum-refractory mUC patients, 24% had TLS, but no significant difference in NLR between groups with or without TLS was found.
  • * The research showed that lower NLR patients with TLS had longer overall survival and progression-free survival, while these benefits were not seen in higher NLR patients, suggesting that the presence of TLS may correlate with better treatment outcomes in specific patient groups.
View Article and Find Full Text PDF
Article Synopsis
  • Genetic testing methods like sequencing analysis and MLPA are typically used to diagnose familial adenomatous polyposis (FAP), but some genetic changes can be hard to detect.
  • A case study of a woman with FAP showed that complex genomic rearrangements could be identified through advanced techniques such as multigene panel testing, chromosomal analysis, and long-read sequencing.
  • The study highlights the importance of using comprehensive genomic analyses when standard testing fails to find genetic variants, especially in patients with a relevant medical or family history of hereditary cancer syndromes.
View Article and Find Full Text PDF
Article Synopsis
  • Recent studies show that cancer mutations can evolve in normal tissues, which may lead to cancer development, but we still need to understand the sequence of events that trigger this transformation.
  • By analyzing samples from both cancerous and non-cancerous lesions, researchers identified specific evolutionary pathways in breast cancers with a common mutation (der(1;16)), revealing a timeline from early puberty to late adolescence before cancer clones emerged.
  • The research indicates that multiple independent cancer clones can arise from non-cancerous ancestors within the breast tissue, leading to varied tumor characteristics, and highlights the influence of local environments on cancer development.
View Article and Find Full Text PDF

Patients with von Hippel-Lindau disease (vHL) are at risk of developing spatially and temporally multiple clear cell renal cell carcinomas (ccRCCs), which offers a valuable opportunity to analyze inter- and intra-tumor heterogeneity of genetic and immune profiles within the same patient. Here, we perform whole-exome and RNA sequencing, digital gene expression, and immunohistochemical analyses for 81 samples from 51 ccRCCs of 10 patients with vHL. Inherited ccRCCs are clonally independent and have less genomic alterations than sporadic ccRCCs.

View Article and Find Full Text PDF

We present our novel software, nanomonsv, for detecting somatic structural variations (SVs) using tumor and matched control long-read sequencing data with a single-base resolution. The current version of nanomonsv includes two detection modules, Canonical SV module, and Single breakend SV module. Using tumor/control paired long-read sequencing data from three cancer and their matched lymphoblastoid lines, we demonstrate that Canonical SV module can identify somatic SVs that can be captured by short-read technologies with higher precision and recall than existing methods.

View Article and Find Full Text PDF
Article Synopsis
  • Pediatric acute myeloid leukemia (AML) shows poor outcomes, and this study focused on identifying genetic abnormalities in TP53 and RB1 genes among 328 pediatric patients.
  • Alterations in TP53 (2.1%) and RB1 (1.8%) were found mostly in patients without specific gene rearrangements, and these alterations were linked to significantly worse survival rates.
  • The study highlights how gene expression changes related to energy metabolism and protein secretion, along with specific gene markers, may aid in tailoring future therapies for pediatric AML.
View Article and Find Full Text PDF

Azacitidine is a mainstay of therapy for myelodysplastic syndrome (MDS)-related diseases. The purpose of our study is to elucidate the effect of gene mutations on hematological response and overall survival (OS), particularly focusing on their posttreatment clone size. We enrolled a total of 449 patients with MDS or related myeloid neoplasms.

View Article and Find Full Text PDF

Gastric cancer is among the most common malignancies worldwide, characterized by geographical, epidemiological and histological heterogeneity. Here, we report an extensive, multiancestral landscape of driver events in gastric cancer, involving 1,335 cases. Seventy-seven significantly mutated genes (SMGs) were identified, including ARHGAP5 and TRIM49C.

View Article and Find Full Text PDF